Invezz

Exponent (EXPO)

Nasdaq Market Open

Exponent Inc. is a specialist consulting firm that applies science, engineering, health, and regulatory expertise to complex technical problems. The company is best known for work involving failure analysis, product safety, risk assessment, regulatory support, and litigation-related consulting. Its clients include corporations, insurers, government agencies, law firms, and other organisations that need independent technical analysis.

The company operates mainly through two business areas. Its engineering and other scientific segment is the larger contributor and covers disciplines such as biomechanics, biomedical engineering, materials science, civil engineering, construction consulting, mechanical engineering, electrical engineering, human factors, and accident reconstruction. This work can involve investigating product failures, evaluating infrastructure issues, assessing vehicle or medical device performance, or helping clients understand the technical causes of incidents.

Exponent’s environmental and health segment focuses on areas including chemical regulation, food safety, toxicology, ecological sciences, environmental science, earth sciences, and health risk assessment. This segment supports clients facing regulatory filings, environmental claims, safety reviews, and scientific questions linked to chemicals, consumer products, industrial operations, and public health.

The firm’s business model depends on highly qualified consultants, many with advanced scientific or engineering credentials. Revenue is generated primarily from professional services, with demand driven by product development, regulation, disputes, recalls, accidents, and broader risk-management needs. Exponent generates most of its revenue in the United States, although its expertise can be applied to global matters. Its distinguishing feature is the breadth of technical disciplines it can combine when clients face problems that require rigorous, evidence-based analysis.

61.42 USD
+1.44 (+2.40%)

Last updated

Market Cap
$2,909,727,507
P/E
26.71
P/FCF
25.66
P/S
4.95
Enterprise Value
$2,791,174,507
Sector
Industrials
Industry
Management Consulting Services
Address
EXPONENT INC, MENLO PARK, CA, 94025
Market Cap
$2,909,727,507
Enterprise Value
$2,791,174,507
P/E
26.71
P/B
8.6
P/S
4.95
EV / EBITDA
22.01
EV / Sales
4.74
EPS
2.25
Dividend Yield
2.12%
P/FCF
25.66
P/CF
23.56
Free Cash Flow
$113,392,000
ROE
32.2%
ROA
15.85%
Debt / Equity
0
Current Ratio
2.4
Quick Ratio
2.4
Cash
0.83
Avg Volume
$600,326
Fundamentals Snapshot Price
59.98

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 151.82M 147.43M 147.12M 141.96M 137.44M
Cost of revenue 0 0 0 0 0
Gross profit 151.82M 147.43M 147.12M 141.96M 137.44M
Operating income 41.38M 29.14M 29.04M 17.18M 44.43M
EBITDA 43.89M 31.68M 31.57M 19.7M 46.92M
Net income 29.57M 24.76M 28.04M 26.55M 26.65M
Income taxes 12.77M 9.34M 10.57M 10.26M 11.11M
Other operating expenses 12.83M 30.68M 22.7M 21.17M 12.1M
Total operating expenses 110.44M 118.29M 118.08M 124.79M 93.01M
Basic EPS 0.59 0.49 0.55 0.52 0.52
Diluted EPS 0.59 0.49 0.55 0.52 0.52

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 687.38M 777.52M 761.45M 759.43M 763.24M
Total liabilities 349.04M 387.18M 358.59M 331.65M 321.83M
Total equity 338.34M 390.34M 402.86M 427.78M 441.41M
Cash & equivalents 118.55M 221.93M 207.38M 231.8M 245.11M
Current assets 340.89M 427.58M 416.79M 425.65M 432.8M
Current liabilities 142.2M 178M 154.77M 134.97M 130.27M
Accounts payable 37.35M 30.94M 26.45M 25.27M 36.78M
Receivables 197.34M 181.51M 182M 171.01M 166.79M
Goodwill 8.61M 8.61M 8.61M 8.61M 8.61M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow -975K 55.58M 32.65M 36.22M 7.27M
Investing cash flow -2.45M -2.69M -2.68M -2.27M -1.75M
Financing cash flow -99.68M -38.4M -54.51M -47.47M -20.05M
Change in cash -103.38M 14.55M -24.42M -13.31M -13.79M
Net income 29.57M 24.76M 28.04M 26.55M 26.65M
Kind Filing Date Link
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
edgar index 4 — EXPONENT INC View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
edgar index 8-K — EXPONENT INC View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
form 4 Form 4 — Zumwalt Debra View Filing
form 4 Form 4 — RICHARDSON KAREN A View Filing
form 4 Form 4 — Brown George H. View Filing
form 4 Form 4 — Lindstrom Carol View Filing
form 4 Form 4 — JOHNSTON PAUL R View Filing
form 4 Form 4 — JOHNSTON PAUL R View Filing
form 4 Form 4 — Zumwalt Debra View Filing
form 4 Form 4 — Zumwalt Debra View Filing
form 4 Form 4 — RICHARDSON KAREN A View Filing
form 4 Form 4 — RICHARDSON KAREN A View Filing
form 4 Form 4 — RICHARDSON KAREN A View Filing
form 4 Form 4 — Brown George H. View Filing
form 4 Form 4 — Brown George H. View Filing
form 4 Form 4 — Lindstrom Carol View Filing
form 4 Form 4 — Lindstrom Carol View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — James Bradley A View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Reiss Richard View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
form 4 Form 4 — Corrigan Catherine View Filing
edgar index SCHEDULE 13G/A — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
edgar index 144 — EXPONENT INC View Filing
form 4 Form 4 — Sala Joseph View Filing
form 4 Form 4 — Rakow Joseph View Filing
edgar index 3 — EXPONENT INC View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
form 3 Form 3 — ANDERSON ERIC R View Filing
edgar index 10-Q — EXPONENT INC View Filing
edgar index 8-K — EXPONENT INC View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — EXPONENT INC View Filing
edgar index SCHEDULE 13G — EXPONENT INC View Filing
edgar index ARS — EXPONENT INC View Filing
edgar index DEF 14A — EXPONENT INC View Filing
edgar index 4 — EXPONENT INC View Filing
  • Trusted by 1M+ investors
  • Global coverage
  • Real-time market data
  • Independent & unbiased

Join thousands making smarter investment decisions.

Get started for free